✦ LIBER ✦

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer

✍ Scribed by Gabriel Glockzin; Nabil Ghali; Sven A. Lang; Hans J. Schlitt; Pompiliu Piso

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 168 KB
Volume: 100
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21332

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significant morbidity rate. Thus, the operative risk has to be evaluated against the background of the expected improvement of the oncological outcome. J. Surg. Oncol. 2009;100:306–310. © 2009 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Cytoreductive surgery and hyperthermic i

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

✍ Jan Franko; Zuhaib Ibrahim; Niraj J. Gusani; Matthew P. Holtzman; David L. Bartl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Cytoreductive surgery and intraperitonea

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma

✍ Samuel P. Jacks; Jonathan C. Hundley; Perry Shen; Greg B. Russell; Edward A. Lev 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Introduction: Peritoneal carcinomatosis (PC) is associated with a dismal prognosis. Small bowel adenocarcinoma is a rare etiology for PC. Due to the rarity, poor prognosis, and lack of standard treatment, we chose to review our experience with this disease process treated with cytoreductive surgery

Postoperative Infections in Cytoreductiv

Postoperative Infections in Cytoreductive Surgery With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis

✍ A. Capone; M. Valle; F. Proietti; O. Federici; A. Garofalo; N. Petrosillo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

## Abstract ## Background Peritoneal carcinomatosis is a common evolution of many abdominal and pelvic malignancies. Over the last decade novel therapeutic approaches have emerged combining cytoreductive surgery with perioperative intraperitoneal chemotherapy. Aim of our study was to assess freque

Peritoneal carcinomatosis from colorecta

Peritoneal carcinomatosis from colorectal cancer: The need for improving selection criteria for cytoreductive surgery and intraperitoneal chemotherapy

✍ Samuel Aguiar Jr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Intraoperative hyperthermic intraperiton

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model

✍ Y. L. B. Klaver; T. Hendriks; R. M. L. M. Lomme; H. J. T. Rutten; R. P. Bleichro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Outcomes of elderly patients undergoing

Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis

✍ Yvonne L.B. Klaver; Terence C. Chua; Ignace H.J.T. de Hingh; David L. Morris 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## Background The combined treatment of cytoreductive surgery (CRS) and perioperative chemotherapy (PIC) for colorectal peritoneal carcinomatosis (PC) is a rigorous surgical treatment most suited for fit and young patients. With technical maturity and improved perioperative care, we ex